UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
71 hedge funds and large institutions have $21.3M invested in Unity Biotechnology in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
19% less call options, than puts
Call options by funds: $250K | Put options by funds: $309K
41% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 29
49% less capital invested
Capital invested by funds: $42M → $21.3M (-$20.7M)
Holders
71
Holding in Top 10
2
Calls
$250K
Puts
$309K
Top Buyers
| 1 | +$1.12M | |
| 2 | +$638K | |
| 3 | +$539K | |
| 4 |
Two Sigma Advisers
New York
|
+$536K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$405K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$686K | |
| 3 | -$504K | |
| 4 |
Morgan Stanley
New York
|
-$476K |
| 5 |
BlackRock
New York
|
-$475K |